Literature DB >> 32590385

Mechanical Ventilation Strategy Guided by Transpulmonary Pressure in Severe Acute Respiratory Distress Syndrome Treated With Venovenous Extracorporeal Membrane Oxygenation.

Rui Wang1, Bing Sun, Xuyan Li, Xiao Tang, Hangyong He, Ying Li, Xue Yuan, Haichao Li, Huiwen Chu, Zhaohui Tong.   

Abstract

OBJECTIVES: Previous studies have suggested that adjusting ventilator settings based on transpulmonary pressure measurements may minimize ventilator-induced lung injury, but this has never been investigated in patients with severe acute respiratory distress syndrome supported with venovenous extracorporeal membrane oxygenation. We aimed to evaluate whether a transpulmonary pressure-guided ventilation strategy would increase the proportion of patients successfully weaned from venovenous extracorporeal membrane oxygenation support in patients with severe acute respiratory distress syndrome.
DESIGN: Single-center, prospective, randomized controlled trial.
SETTING: Sixteen-bed, respiratory ICU at a tertiary academic medical center. PATIENTS: Severe acute respiratory distress syndrome patients receiving venovenous extracorporeal membrane oxygenation.
INTERVENTIONS: One-hundred four patients were randomized to transpulmonary pressure-guided ventilation group (n = 52) or lung rest strategy group (n = 52) groups. Two patients had cardiac arrest during establishment of venovenous extracorporeal membrane oxygenation in the lung rest group did not receive the assigned intervention. Thus, 102 patients were included in the analysis.
MEASUREMENTS AND MAIN RESULTS: The proportion of patients successfully weaned from venovenous extracorporeal membrane oxygenation in the transpulmonary pressure-guided group was significantly higher than that in the lung rest group (71.2% vs 48.0%; p = 0.017). Compared with the lung rest group, driving pressure, tidal volumes, and mechanical power were significantly lower, and positive end-expiratory pressure was significantly higher, in the transpulmonary pressure-guided group during venovenous extracorporeal membrane oxygenation support. In the transpulmonary pressure-guided group, levels of interleukin-1β, interleukin-6, and interleukin-8 were significantly lower, and interleukin-10 was significantly higher, than those of the lung rest group over time. Lung density was significantly lower in the transpulmonary pressure-guided group after venovenous extracorporeal membrane oxygenation support than in the lung rest group.
CONCLUSIONS: A transpulmonary pressure-guided ventilation strategy could increase the proportion of patients with severe acute respiratory distress syndrome successfully weaned from venovenous extracorporeal membrane oxygenation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32590385     DOI: 10.1097/CCM.0000000000004445

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Extracorporeal Gas Exchange for Acute Respiratory Distress Syndrome: Open Questions, Controversies and Future Directions.

Authors:  Marco Giani; Simone Redaelli; Antonio Siragusa; Benedetta Fumagalli; Roberto Rona; Giuseppe Foti
Journal:  Membranes (Basel)       Date:  2021-02-28

Review 2.  Efficacy of Higher Positive End-Expiratory Pressure Ventilation Strategy in Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Ryohei Yamamoto; Sosuke Sugimura; Kazuki Kikuyama; Chihiro Takayama; Junichi Fujimoto; Koichi Yamashita; Yasuhiro Norisue; Chihiro Narita
Journal:  Cureus       Date:  2022-07-18

Review 3.  Extracorporeal life support for adults with acute respiratory distress syndrome.

Authors:  Alain Combes; Matthieu Schmidt; Carol L Hodgson; Eddy Fan; Niall D Ferguson; John F Fraser; Samir Jaber; Antonio Pesenti; Marco Ranieri; Kathryn Rowan; Kiran Shekar; Arthur S Slutsky; Daniel Brodie
Journal:  Intensive Care Med       Date:  2020-11-02       Impact factor: 17.440

4.  Predicting candidate therapeutic drugs for sepsis-induced acute respiratory distress syndrome based on transcriptome profiling.

Authors:  Jiawei Ma; Qianqian Li; Dandan Ji; Liang Hong; Lei Luo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.